News about Global Pharma

ZEISS CLARUS 700 Receives NMPA Approval in China, Advancing Retinal Imaging Technology

ZEISS Medical Technology announced that the CLARUS® 700 from ZEISS has received National Medical Products Administration (NMPA) approval in China, offering advanced retinal diagnostic capabilities with ultra-widefield, high-resolution images in True Color and unsurpassed quality.

Global Pharma | 06/06/2025 | By Manvi |  142

Alvotech, Dr. Reddy's Join Hands to Co-Develop Biosimilar Candidate to Keytruda (pembrolizumab)

Alvotech and Dr. Reddy's Laboratories have entered into a global collaboration to co-develop, manufacture, and commercialise a biosimilar of Keytruda (pembrolizumab), aiming to expand access to affordable cancer treatments worldwide.

Global Pharma | 05/06/2025 | By Manvi |  212

Mindset Medical Receives FDA Clearance for Contactless Vital Sign Monitoring App

Mindset Medical, Inc. announced it has received US Food and Drug Administration (FDA) 510(k) clearance for its latest contactless vital sign monitoring solution.

Global Pharma | 05/06/2025 | By Manvi |  209

Medline Announces New Prime Vendor Agreement with The Ohio State University Wexner Medical Center

As part of the agreement, Medline will provide a portfolio of medical-surgical products and supply chain optimization solutions to the health system's more than 100 facilities to support their operational efficiency and clinical delivery goals.

Global Pharma | 05/06/2025 | By Manvi

Arthrex Launches Synergy Power for Versatile Orthopedic Procedures

Arthrex announces the launch of Synergy Power™, a versatile and reliable battery-powered system designed for a wide variety of orthopedic applications.

Global Pharma | 04/06/2025 | By Manvi |  126

Tixel i Shows Strong, Lasting Results for Dry Eye Treatment in JOJ Ophthalmology Study

This FDA-cleared, non-invasive device uses patented Thermo-Mechanical Action® (TMA®) to deliver durable improvements in key indicators, including patient satisfaction and clinical results.

Global Pharma | 04/06/2025 | By Manvi |  135

Gland Pharma Secures Approval for Angiotensin II Acetate Injection

Gland Pharma has received USFDA approval for its Angiotensin II Acetate Injection, securing 180-day exclusivity as the First-to-File generic of GIAPREZA for treating distributive shock.

Global Pharma | 04/06/2025 | By Manvi |  187

UK's MHRA Grants Approval to Aumolertinib for Treatment of Non-Small Cell Lung Cancer

The UK’s MHRA has approved aumolertinib (Aumseqa) for adults with advanced non-small cell lung cancer carrying EGFR mutations, offering a new targeted treatment option for metastatic cases.

Global Pharma | 04/06/2025 | By Manvi |  399

Perma and UE Systems Launch UltraTrak VARIO for Smart Industrial Lubrication

perma has joined forces with UE Systems to redefine industrial lubrication. Central to this strategic partnership is the launch of the UltraTrak VARIO, a new solution within the OnTrak Wireless ecosystem.

Global Pharma | 03/06/2025 | By Manvi |  355

Johnson & Johnson MedTech Launches KINCISE 2 Surgical Automation System

Johnson & Johnson MedTech announced the launch of the KINCISE 2™ Surgical Automated System, a next-generation automated power tool engineered to improve surgical efficiency, provide control and aims to reduce physical burden on surgeons compared to manual impaction across both primary and revision hip and revision knee replacement procedures.

Global Pharma | 03/06/2025 | By Manvi |  255